Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

SRx Health Solutions (SRXH) Leases (2019 - 2025)

SRx Health Solutions' Leases history spans 7 years, with the latest figure at $20000.0 for Q3 2025.

  • For Q3 2025, Leases fell 99.69% year-over-year to $20000.0; the TTM value through Sep 2025 reached $20000.0, down 99.69%, while the annual FY2025 figure was $20000.0, N/A changed from the prior year.
  • Leases reached $20000.0 in Q3 2025 per SRXH's latest filing, down from $4.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $6.5 million in Q3 2024 to a low of $20000.0 in Q3 2025.
  • Average Leases over 5 years is $687210.5, with a median of $106000.0 recorded in 2024.
  • The largest YoY upside for Leases was 5027.17% in 2025 against a maximum downside of 99.69% in 2025.
  • A 5-year view of Leases shows it stood at $56000.0 in 2021, then skyrocketed by 208.93% to $173000.0 in 2022, then tumbled by 30.64% to $120000.0 in 2023, then tumbled by 46.67% to $64000.0 in 2024, then tumbled by 68.75% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Leases are $20000.0 (Q3 2025), $4.7 million (Q2 2025), and $50000.0 (Q1 2025).